Observation Notes 2
OBSERVATION NOTES: SUBJECT 13 PHASE I, DAY 1 Subject is Male, 5’9, 212 lbs. 47 years old. Showing signs of confusion as sedatives wear off. Formula has been injected while unconscious without event. Formula 12-B has been approved for testing, with close observation applied to ensure racial and psychological modifications match expected profile. Beginning observation for stage one. DAY 5 Subject is threatening legal action towards any staff interacted with. Reluctantly eats meals enough to maintain dosage necessary for further physical progress. Weight loss is more pronounced than in previous subjects, height loss is still minimal. DAY 15 Like previous formula, subject is increasingly docile. Interactions with staff are increasingly positive, with little mention of Subject’s previous identity. Physical changes have accelerated, including weight loss, reduction in perceived age, minor loss in height, and significant redistribution of fat towards the breasts and rear. Skin is noticeably m...